Reprogramming Somatic Cells into iPSCs Engineered with an Anti-PSCA CAR to Develop Allogeneic Off-the-Shelf Cell Therapy to Treat Pancreatic Cancer

  • Post author:
  • Post category:

Research Objective Our candidate product PSCA-CAR_s15 uiNK is derived from transduction of iPSCs selected from the most ideal source and episomally reprogrammed from mature NK cells or CD34+ cells. Impact…

Continue ReadingReprogramming Somatic Cells into iPSCs Engineered with an Anti-PSCA CAR to Develop Allogeneic Off-the-Shelf Cell Therapy to Treat Pancreatic Cancer

Vax-CT to promote formation of cancer-specific T memory stem cell for personalized cancer immunotherapy

  • Post author:
  • Post category:

Research Objective A vaccine booster to induce antigen-specific T memory stem cells that will help enhance the long-term immunity against cancer recurrence Impact Cancer recurrence presents an unmet medical need.…

Continue ReadingVax-CT to promote formation of cancer-specific T memory stem cell for personalized cancer immunotherapy

CAR T cells targeting abnormal N-glycans for the treatment of refractory/metastatic solid cancers

  • Post author:
  • Post category:

Research Objective Develop genetically modified chimeric antigen receptor T cells to kill incurable solid cancers by targeting a previously un-targetable tumor associated carbohydrate antigen. Impact Refractory/metastatic solid cancers are almost…

Continue ReadingCAR T cells targeting abnormal N-glycans for the treatment of refractory/metastatic solid cancers

Combating Ovarian Cancer Using Stem Cell-Engineered Off-The-Shelf CAR-iNKT Cells

  • Post author:
  • Post category:

Research Objective HSC-engineered allogeneic mesothelin-targeting CAR-iNKT (AlloMCAR-iNKT) cells Impact treatment of ovarian cancer Major Proposed Activities Milestone 1. Production of the AlloMCAR-iNKT cellsMilestone 2. Characterization of the AlloMCAR-iNKT cellsMilestone 3.…

Continue ReadingCombating Ovarian Cancer Using Stem Cell-Engineered Off-The-Shelf CAR-iNKT Cells